500-1,000
These external shocks introduce uncertainty, potentially stalling growth initiatives and deterring long-term investment in the Acetyl-L Carnitine market
This variability affects metabolic outputs, including the production of metabolites like trimethylamine (TMA)
No Phase I, II, or III trial has been completed and published in a peer-reviewed journal with systematic adverse-event reporting
It has been suggested that those with fatty liver disease may have lower circulating levels of L-carnitine for this, or other, reasons 2
Sideeffects are mild and transientdrowsiness, brief headache, vivid dreams, or occasional injectionsite irritationwithout tolerance or dependence Potential side effects include injection site irritation, headache, vivid dreams, and hormonerelated effects